HomeSarepta Therapeutics

Sarepta Therapeutics

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The company notes employees received, in the aggregate, options to purchase 20,835 shares of Sarepta's common stock, and in the aggregate, 8,385 restricted stock units.